The Stanley Brothers has offered large investors in its Birchal crowdfunding raise the opportunity to buy additional shares at the current offer price of 35 cents per share for up to two years. 

In what it claimed was an Australian first for equity crowdfunding, the firm said the deal will apply to those investing over A$50k in the raise, which closes today (Thursday).

It added there will be no upfront costs for the warrant, with no obligation on investors to buy additional shares. 

Stanley Brothers co-founder Jesse Stanley

At at 8.40am today, Stanley Brothers has raised $746k from 439 investors as part of its stated plan to build an “army of advocates” to lobby for regulatory reform in Australia.

According to its prospectus, the company is looking to raise a maximum of $3m. 

Meanwhile, via its joint venture with FoliuMed, Stanley Brothers said it is “actively pursuing” deals in the US, Brazil, Colombia, Germany, and other European Union countries following its Australian launch.

It added: “Unlike typical international cannabis brands that operate locally or within a single market, Stanley Brothers is set to become the first globally recognised brand in medical cannabis. This ambition sets a new benchmark in the industry. Australia is paramount to this.”

FoliuMed, which conducts manufacturing and R&D in Germany and cultivation in South America, revealed last year it had teamed up with the Stanley Brothers to launch in Australia. 

The two firms are collaborating to initially offer three medicines via the Special Access Scheme with a broader product range to follow.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...

Leave a comment